Pharmafile Logo

Bridging Gaps with Virtual Meetings – Perks of Virtual Medical Education

Learn how virtual meetings can be used to review new data and minimize lengthy presentations, making every in-person interaction more productive and focused. Dive into the synergistic benefits of combining virtual and face-to-face meetings for a richer educational experience.

Discover how virtual meetings complement and enhance in-person interactions in our eighth video from the “Perks of Virtual Medical Education” series. Learn why virtual environments are indispensable tools for continuity in education and collaboration.

8. Virtual Meetings as a Supplement to In-Person Events Virtual meetings are not merely alternatives to in-person gatherings; they serve as essential supplements that enrich the overall meeting experience. By filling the “white space” between live events, virtual meetings prepare participants effectively, allowing them to engage with new data and concepts beforehand. This pre-meeting engagement reduces the need for extensive didactic presentations during the actual event, making in-person interactions more focused and productive. Virtual tools offer a flexible, efficient way to enhance understanding and readiness, ensuring that every moment of face-to-face time is used to its fullest potential.

For deeper insights into how virtual and in-person meetings can be synergistically integrated to maximize educational outcomes, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your educational strategies with Impetus Digital:

Stay connected for more innovative educational tips:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...

Scanning for Health Indicators and Risks Through Your Smartphone

Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging, dives into the implications of increased integration of tech and data into daily life for the...

Virtual MSL/Sales training programs and events

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...

The Future of MedTech: Streamlined Clinical Data Collection & Management

Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!

Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?

With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and...